Genotype Hormones Life Science Trials 
XTalks
SEPTEMBER 15, 2020
A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals. The DIAGNODE-2 Trial.
The Pharma Data
DECEMBER 9, 2020
The creation of Overland isn’t the only exciting thing happening for international life sciences companies and organizations. announced a research collaboration to develop hormone receptor antagonist (GHRA) peptides as potential treatments for acromegaly, a rare but serious endocrine disorder with significant unmet medical need.
Expert insights. Personalized for you.
103 
Let's personalize your content